Home LiteratureArticle Details
PMID: 8294003 Published · ppublish English Journal Article

A versatile and highly repressible Escherichia coli expression system based on invertible promoters: expression of a gene encoding a toxic product.

Gene ·Vol. 136 ·No. 1-2 ·1993-12-22 ·Pages 199-203

Wülfing C, Plückthun A

Abstract

A very flexible and tightly regulatable expression system has been constructed. It uses the principle of invertible promoters [Podhajska et al., Gene 40 (1985) 163-168]. Here, we describe the construction of a plasmid that provides the integrase, which causes promoter inversion in a tightly regulated fashion, as well as modified plasmids carrying the invertible module. The way the integrase is provided on a separate plasmid closely mimicks expression of the integrase from a lambda lysogen. Thus, the flexibility of the original system is considerably extended by making it strain-independent without compromising the tight regulation. We present the expression of a single-chain T-cell receptor fragment as an example of application, in order to illustrate the properties of this expression system.

MeSH Terms
Amino Acid Sequence Base Sequence Cloning, Molecular/methods DNA Nucleotidyltransferases/genetics Escherichia coli/genetics Integrases Molecular Sequence Data Plasmids Promoter Regions, Genetic Receptors, Antigen, T-Cell/genetics
Chemicals
Receptors, Antigen, T-Cell DNA Nucleotidyltransferases Integrases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wülfing C
Protein Engineering Group, Max-Planck-Institut für Biochemie, Martinsried, Germany.
Plückthun A
Article Info
Journal
Gene
Abbr.
Gene
ISSN
0378-1119
Published
1993-12-22
Pages
199-203
Language
English
Region
Netherlands
NLM ID
7706761
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com